Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls

Cancer Letters

Volumn 347, Issue 1, 2014, Pages 46-53

  Lee, Jihyoun ^a,b   Chatterjee, Dev Kumar ^a   Lee, Min Hyuk ^b   Krishnan, Sunil ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Breast neoplasms; Gold nanoparticle; Nanotechnology; Theranostics

Indexed keywords

GOLD NANOPARTICLE; TRASTUZUMAB;

BREAST CANCER; CANCER GENE THERAPY; CANCER RESEARCH; CELL TRANSPORT; CELLULAR DISTRIBUTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC THERAPY; KIDNEY CLEARANCE; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; RISK ASSESSMENT; SHORT SURVEY; TISSUE DISTRIBUTION; TOXICITY TESTING; TUMOR ABLATION; TUMOR CELL DESTRUCTION;

BREAST NEOPLASMS; GOLD NANOPARTICLE; NANOTECHNOLOGY; THERANOSTICS;

BREAST NEOPLASMS; FEMALE; GOLD; HUMANS; HYPERTHERMIA, INDUCED; METAL NANOPARTICLES; RADIATION-SENSITIZING AGENTS;

EID: 84897097890     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.02.006     Document Type: Review

References (76)

1. DeSantis C., Siegel R., Bandi P., Jemal A. Breast cancer statistics, 2011. CA: Cancer J. Clinicians 2011, 61:409-418.
2. N.A. Howlader, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S.F. Altekruse, C.L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin KA (Eds.), SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute, Bethesda, MD.
3. Yezhelyev M.V., Gao X., Xing Y., Al-Hajj A., Nie S., O'Regan R.M. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006, 7:657-667.
4. Sau T.K., Murphy C.J. Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir: ACS J. Surf. Colloids 2004, 20:6414-6420.
5. Huff T.B., Hansen M.N., Zhao Y., Cheng J.X., Wei A. Controlling the cellular uptake of gold nanorods. Langmuir: ACS J. Surf. Colloids 2007, 23:1596-1599.
6. Hauck T.S., Ghazani A.A., Chan W.C. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 2008, 4:153-159.
7. Kah J.C., Wong K.Y., Neoh K.G., Song J.H., Fu J.W., Mhaisalkar S., Olivo M., Sheppard C.J. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J. Drug Target. 2009, 17:181-193.
8. Hainfeld J.F., Smilowitz H.M., O'Connor M.J., Dilmanian F.A., Slatkin D.N. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomed. (Lond.) 2013, 8:1601-1609.
9. Prades R., Guerrero S., Araya E., Molina C., Salas E., Zurita E., Selva J., Egea G., Lopez-Iglesias C., Teixido M., Kogan M.J., Giralt E. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials 2012, 33:7194-7205.
10. Weissleder R. A clearer vision for in vivo imaging. Nat. Biotechnol. 2001, 19:316-317.
11. Day E.S., Morton J.G., West J.L. Nanoparticles for thermal cancer therapy. J. Biomech. Eng. 2009, 131:074001.
12. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomed. (Lond.) 2007, 2:681-693.
13. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 2008, 23:217-228.
14. O'Neal D.P., Hirsch L.R., Halas N.J., Payne J.D., West J.L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004, 209:171-176.
15. Lal S., Clare S.E., Halas N.J. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc. Chem. Res. 2008, 41:1842-1851.
16. Roeske J.C., Nunez L., Hoggarth M., Labay E., Weichselbaum R.R. Characterization of the theoretical radiation dose enhancement from nanoparticles. Technol. Cancer Res. Treat. 2007, 6:395-401.
17. Zhang S.X., Gao J., Buchholz T.A., Wang Z., Salehpour M.R., Drezek R.A., Yu T.K. Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study. Biomed. Microdev. 2009, 11:925-933.
18. Herold D.M., Das I.J., Stobbe C.C., Iyer R.V., Chapman J.D. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int. J. Radiat. Biol. 2000, 76:1357-1364.
19. Zheng Y., Hunting D.J., Ayotte P., Sanche L. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat. Res. 2008, 169:19-27.
20. Prise K.M., Schettino G., Folkard M., Held K.D. New insights on cell death from radiation exposure. Lancet Oncol. 2005, 6:520-528.
21. Huang K., Ma H., Liu J., Huo S., Kumar A., Wei T., Zhang X., Jin S., Gan Y., Wang P.C., He S., Liang X.J. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 2012, 6:4483-4493.
22. Zhang W., Ji Y., Wu X., Xu H. Trafficking of gold nanorods in breast cancer cells: uptake, lysosome maturation, and elimination. ACS Appl. Mater. Interfaces 2013, 5:9856-9865.
23. Hillyer J.F., Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharmaceut. Sci. 2001, 90:1927-1936.
24. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
25. Alric C., Miladi I., Kryza D., Taleb J., Lux F., Bazzi R., Billotey C., Janier M., Perriat P., Roux S., Tillement O. The biodistribution of gold nanoparticles designed for renal clearance. Nanoscale 2013, 5:5930-5939.
26. Libutti S.K., Paciotti G.F., Byrnes A.A., Alexander H.R., Gannon W.E., Walker M., Seidel G.D., Yuldasheva N., Tamarkin L. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clinical Cancer Res.: An Off. J. Am. Assoc. Cancer Res. 2010, 16:6139-6149.
27. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
28. Lasagna-Reeves C., Gonzalez-Romero D., Barria M.A., Olmedo I., Clos A., Sadagopa Ramanujam V.M., Urayama A., Vergara L., Kogan M.J., Soto C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Res. Commun. 2010, 393:649-655.
29. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
30. Love S.A., Thompson J.W., Haynes C.L. Development of screening assays for nanoparticle toxicity assessment in human blood: preliminary studies with charged Au nanoparticles. Nanomedi. (Lond.) 2012.
31. Glazer E.S., Zhu C., Hamir A.N., Borne A., Thompson C.S., Curley S.A. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology 2011, 5:459-468.
32. Asharani P.V., Lianwu Y., Gong Z., Valiyaveettil S. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 2011, 5:43-54.
33. Gad S.C., Sharp K.L., Montgomery C., Payne J.D., Goodrich G.P. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells). Int. J. Toxicol. 2012, 31:584-594.
34. Hainfeld J.F., Slatkin D.N., Smilowitz H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 2004, 49:N309-N315.
35. Jain S., Coulter J.A., Hounsell A.R., Butterworth K.T., McMahon S.J., Hyland W.B., Muir M.F., Dickson G.R., Prise K.M., Currell F.J., O'Sullivan J.M., Hirst D.G. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int. J. Radiat. Oncol., Biol., Phys. 2011, 79:531-539.
36. Butterworth K.T., McMahon S.J., Currell F.J., Prise K.M. Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 2012, 4:4830-4838.
37. Kauer-Dorner D., Potter R., Resch A., Handl-Zeller L., Kirchheiner K., Meyer-Schell K., Dorr W. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother. Oncol.: J. Eur. Soc. Therap. Radiol. Oncol. 2012, 102:96-101.
38. Hirsch L.R., Stafford R.J., Bankson J.A., Sershen S.R., Rivera B., Price R.E., Hazle J.D., Halas N.J., West J.L. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 2003, 100:13549-13554.
39. Loo C., Lowery A., Halas N., West J., Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005, 5:709-711.
40. Lowery A.R., Gobin A.M., Day E.S., Halas N.J., West J.L. Immunonanoshells for targeted photothermal ablation of tumor cells. Int. J. Nanomed. 2006, 1:149-154.
41. Loo C., Lin A., Hirsch L., Lee M.H., Barton J., Halas N., West J., Drezek R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat. 2004, 3:33-40.
42. Zharov V.P., Galitovskaya E.N., Johnson C., Kelly T. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. Lasers Surg. Med. 2005, 37:219-226.
43. Hildebrandt B., Wust P., Ahlers O., Dieing A., Sreenivasa G., Kerner T., Felix R., Riess H. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol./Hematol. 2002, 43:33-56.
44. Jones E.L., Oleson J.R., Prosnitz L.R., Samulski T.V., Vujaskovic Z., Yu D., Sanders L.L., Dewhirst M.W. Randomized trial of hyperthermia and radiation for superficial tumors. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2005, 23:3079-3085.
45. Zagar T.M., Oleson J.R., Vujaskovic Z., Dewhirst M.W., Craciunescu O.I., Blackwell K.L., Prosnitz L.R., Jones E.L. Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data. Int. J. Hyperthermia: Off. J. Eur. Soc. Hyperthermic Oncol., North American Hyperthermia Group 2010, 26:612-617.
46. Atkinson R.L., Zhang M., Diagaradjane P., Peddibhotla S., Contreras A., Hilsenbeck S.G., Woodward W.A., Krishnan S., Chang J.C., Rosen J.M. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci. Transl. Med. 2010, 2. (55ra79).
47. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., Tamarkin L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11:169-183.
48. Huschka R., Zuloaga J., Knight M.W., Brown L.V., Nordlander P., Halas N.J. Light-induced release of DNA from gold nanoparticles: nanoshells and nanorods. J. Am. Chem. Soc. 2011, 133:12247-12255.
49. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. J. Am. Chem. Soc. 2007, 129:11653-11661.
50. Liu H., Chen D., Li L., Liu T., Tan L., Wu X., Tang F. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew. Chem. Int. Ed. Engl. 2011, 50:891-895.
51. Kim S.T., Chompoosor A., Yeh Y.C., Agasti S.S., Solfiell D.J., Rotello V.M. Dendronized gold nanoparticles for siRNA delivery. Small 2012.
52. 4 nanoparticles for target-specific platin delivery. J. Am. Chem. Soc. 2009, 131:4216-4217.
53. Joshi P., Chakraborti S., Ramirez-Vick J.E., Ansari Z.A., Shanker V., Chakrabarti P., Singh S.P. The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells. Colloid Surface B 2012, 95:195-200.
54. Kuo T.R., Hovhannisyan V.A., Chao Y.C., Chao S.L., Chiang S.J., Lin S.J., Dong C.Y., Chen C.C. Multiple release kinetics of targeted drug from gold nanorod embedded polyelectrolyte conjugates induced by near-infrared laser irradiation. J. Am. Chem. Soc. 2010, 132:14163-14171.
55. You J., Zhang R., Zhang G., Zhong M., Liu Y., Van Pelt C.S., Liang D., Wei W., Sood A.K., Li C. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J. Control Release: Off. J. Control. Release Soc. 2012, 158:319-328.
56. Chattopadhyay N., Cai Z., Pignol J.P., Keller B., Lechtman E., Bendayan R., Reilly R.M. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Mol. Pharmaceut. 2010, 7:2194-2206.
57. Chen J., Irudayaraj J. Quantitative investigation of compartmentalized dynamics of ErbB2 targeting gold nanorods in live cells by single molecule spectroscopy. ACS Nano 2009, 3:4071-4079.
58. Eghtedari M., Liopo A.V., Copland J.A., Oraevsky A.A., Motamedi M. Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett. 2009, 9:287-291.
59. Nahta R., Esteva F.J. HER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res.: BCR 2006, 8:215.
60. Carpin L.B., Bickford L.R., Agollah G., Yu T.K., Schiff R., Li Y., Drezek R.A. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells. Breast Cancer Res. Treat. 2011, 125:27-34.
61. Li J.L., Wang L., Liu X.Y., Zhang Z.P., Guo H.C., Liu W.M., Tang S.H. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett. 2009, 274:319-326.
62. Jin H., Hong B., Kakar S.S., Kang K.A. Tumor-specific nano-entities for optical detection and hyperthermic treatment of breast cancer. Adv. Exp. Med. Biol. 2008, 614:275-284.
63. Zhang W., Meng J., Ji Y., Li X., Kong H., Wu X., Xu H. Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system. Nanoscale 2011, 3:3923-3932.
64. Park J., Estrada A., Sharp K., Sang K., Schwartz J.A., Smith D.K., Coleman C., Payne J.D., Korgel B.A., Dunn A.K., Tunnell J.W. Two-photon-induced photoluminescence imaging of tumors using near-infrared excited gold nanoshells. Optics Express 2008, 16:1590-1599.
65. Bickford L., Sun J., Fu K., Lewinski N., Nammalvar V., Chang J., Drezek R. Enhanced multi-spectral imaging of live breast cancer cells using immunotargeted gold nanoshells and two-photon excitation microscopy. Nanotechnology 2008, 19:315102.
66. Bickford L.R., Agollah G., Drezek R., Yu T.K. Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy. Breast Cancer Res. Treat. 2010, 120:547-555.
67. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Brit. J. Radiol. 2006, 79:248-253.
68. Qian X., Peng X.H., Ansari D.O., Yin-Goen Q., Chen G.Z., Shin D.M., Yang L., Young A.N., Wang M.D., Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 2008, 26:83-90.
69. Su C.H., Sheu H.S., Lin C.Y., Huang C.C., Lo Y.W., Pu Y.C., Weng J.C., Shieh D.B., Chen J.H., Yeh C.S. Nanoshell magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2007, 129:2139-2146.
70. Copland J.A., Eghtedari M., Popov V.L., Kotov N., Mamedova N., Motamedi M., Oraevsky A.A. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol. Imag. Biol.: MIB: The Off. Publ. Acad. Mol. Imag. 2004, 6:341-349.
71. Song K.H., Kim C., Cobley C.M., Xia Y., Wang L.V. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett. 2009, 9:183-188.
72. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.T., Liu Z. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
73. Fales A.M., Yuan H., Vo-Dinh T. Silica-coated gold nanostars for combined surface-enhanced Raman scattering (SERS) detection and singlet-oxygen generation: a potential nanoplatform for theranostics. Langmuir: ACS J. Surf. Colloids 2011, 27:12186-12190.
74. Kennedy L.C., Bickford L.R., Lewinski N.A., Coughlin A.J., Hu Y., Day E.S., West J.L., Drezek R.A. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 2011, 7:169-183.
75. Dickerson E.B., Dreaden E.C., Huang X., El-Sayed I.H., Chu H., Pushpanketh S., McDonald J.F., El-Sayed M.A. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008, 269:57-66.
76. Giuliano A.E., Hunt K.K., Ballman K.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W., Leitch A.M., Saha S., McCall L.M., Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA: J. Am. Med. Assoc. 2011, 305:569-575.